This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

We cordially invite everyone to attend a special open house event at the Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy (RMI) at 801 E. Southlake Blvd. in Southlake, Texas 76092 on Friday, March 6th from 5:30 pm to 7:30 pm. There will be plenty of food, drink and engaging conversation with world-renowned stem cell scientist, Neil H.Riordan, PhD and board-certified orthopedic surgeon, R. Wade McKenna, DO.

Southlake, Texas (PRWEB) March 05, 2015

RMI specializes in Stemnexa non-surgical treatment of acute and chronic orthopedic conditions such as meniscal tears, ACL injuries, rotator cuff injuries, runners knee, tennis elbow, and joint pain due to degenerative conditions like osteoarthritis. Stemnexa may also be administered during orthopedic surgeries to promote better post-surgical outcomes.

Stemnexa combines the latest, patented scientific advances in nearly pain-free bone marrow harvesting with two complimentary cellular technologies: Bone Marrow Aspirate Concentrate (BMAC) and *AlphaGEMS amniotic tissue product.

BMAC contains a patients own mesenchymal stem cells (MSC,) hematopoietic stem cells (CD34+), growth factors and other progenitor cells. AlphaGEMS is composed of collagens and other structural proteins, which provide a biologic matrix that supports angiogenesis, tissue growth and new collagen during tissue regeneration and repair.

*AlphaGEMS product is harvested from donated amniotic sac tissue after normal healthy births. For more information about AlphaGEMS, please visit: http://www.rmiclinic.com/non-surgical-stem-cell-injections-joint-pain/stemnexa-protocol/

Find out more about RMI in the February edition of Society Life Magazine.

Riordan-McKenna Institute

Home

Read the original here:
Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas ...

Comments are closed.